Reviva Pharmaceuticals, a clinical-stage biopharmaceutical company, is focused on the development of next-generation neuroreceptor-targeting therapeutics to treat schizophrenia and other ...
Cannabis Disrupts Brain Activity in Young Adults ... The breakthrough paves the way for psychosis treatments ... Multiple Sclerosis Drug May Help With Poor Working Memory Nov.
The pharmacotherapy of schizophrenia is currently dominated ... responding in trained rats and reversed the apomorphine-induced suppression of the acoustic startle response. These results indicate ...
Typical Antipsychotics, or First Generation Antipsychotic Drugs ... of schizophrenia. Many atypical or second generation antipsychotics block serotonin (5-HT) receptors in the brain, particularly ...
This suggests “our TMS protocol may be generalized to other symptoms of schizophrenia ... included TMS-induced electric field strength, using baseline structural brain images; scores on ...